[HTML][HTML] Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological …

S Paul, S Chakraborty, U Anand, S Dey… - Biomedicine & …, 2021 - Elsevier
Abstract Withania somnifera (L.) Dunal (Solanaceae) has been used as a traditional
Rasayana herb for a long time. Traditional uses of this plant indicate its ameliorative …

[HTML][HTML] Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease

S Giordano, V Darley-Usmar, J Zhang - Redox biology, 2014 - Elsevier
Oxidative stress including DNA damage, increased lipid and protein oxidation, are important
features of aging and neurodegeneration suggesting that endogenous antioxidant protective …

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

D Blum, S Torch, N Lambeng, MF Nissou… - Progress in …, 2001 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder characterized by a preferential
loss of the dopaminergic neurons of the substantia nigrapars compacta. Although the …

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP

A Schober - Cell and tissue research, 2004 - Springer
Neurological disorders in humans can be modeled in animals using standardized
procedures that recreate specific pathogenic events and their behavioral outcomes. The …

Animal models of Parkinson's disease

R Betarbet, TB Sherer, JT Greenamyre - Bioessays, 2002 - Wiley Online Library
Animal models are important tools in experimental medical science to better understand
pathogenesis of human diseases. Once developed, these models can be exploited to test …

Structure–activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives

Z Lu, G Nie, PS Belton, H Tang, B Zhao - Neurochemistry international, 2006 - Elsevier
Gallic acid and its derivatives are a group of naturally occurring polyphenol antioxidants
which have recently been shown to have potential healthy effects. In order to understand the …

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

I Lastres-Becker, F Molina-Holgado, JA Ramos… - Neurobiology of …, 2005 - Elsevier
Cannabinoids have been reported to provide neuroprotection in acute and chronic
neurodegeneration. In this study, we examined whether they are also effective against the …

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man

M Gerlach, P Riederer - Journal of neural transmission, 1996 - Springer
Animal models are an important aid in experimental medical science because they enable
one to study the pathogenetic mechanisms and the therapeutic principles of treating the …

Autoxidation and neurotoxicity of 6‐hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease

R Soto‐Otero, E Méndez‐Álvarez… - Journal of …, 2000 - Wiley Online Library
6‐Hydroxydopamine (6‐OHDA) is a dopaminergic neurotoxin putatively involved in the
pathogenesis of Parkinson's disease (PD). Its neurotoxicity has been related to the …

Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

M Ahmad, S Saleem, AS Ahmad… - Human & …, 2005 - journals.sagepub.com
6-Hydroxydopamine (6-OHDA) is one of the most widely used rat models for Parkinson's
disease. There is ample evidence in the literature that 6-OHDA elicits its toxic manifestations …